Small Peptide Derivatives Within the Carbohydrate Recognition Domain of SP-A2 Modulate Asthma Outcomes in Mouse Models and Human Cells

• Published in: Frontiers in immunology Vol. 13; p. 900022
• Main Authors: Francisco, Dave, Wang, Ying, Marshall, Craig, Conway, Michelle, Addison, Kenneth J., Billheimer, Dean, Kimura, Hiroki, Numata, Mari, Chu, Hong W., Voelker, Dennis R., Kraft, Monica, Ledford, Julie G.
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 08.07.2022
• Subjects: Animals; asthma; Asthma - genetics; Carbohydrates; Disease Models, Animal; genetics; Humans; Immunology; Inflammation; Interleukin-13 - genetics; Mice; Pulmonary Surfactant-Associated Protein A - genetics; SP-A; SP-A peptides; surfactant protein; SP-A peptides; asthma; genetics; surfactant protein; SP-A
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2022.900022

Surfactant Protein-A (SP-A) is an innate immune modulator that regulates a variety of pulmonary host defense functions. We have shown that SP-A is dysfunctional in asthma, which could be partly due to genetic heterogeneity. In mouse models and primary bronchial epithelial cells from asthmatic participants, we evaluated the functional significance of a particular single nucleotide polymorphism of SP-A2, which results in an amino acid substitution at position 223 from glutamine (Q) to lysine (K) within the carbohydrate recognition domain (CRD). We found that SP-A 223Q humanized mice had greater protection from inflammation and mucin production after IL-13 exposure as compared to SP-A-2 223K mice. Likewise, asthmatic participants with two copies the major 223Q allele demonstrated better lung function and asthma control as compared to asthmatic participants with two copies of the minor SP-A 223K allele. In primary bronchial epithelial cells from asthmatic participants, full-length recombinant SP-A 223Q was more effective at reducing IL-13-induced MUC5AC gene expression compared to SP-A 223K. Given this activity, we developed 10 and 20 amino acid peptides of SP-A2 spanning position 223Q. We show that the SP-A 223Q peptides reduce eosinophilic inflammation, mucin production and airways hyperresponsiveness in a house dust mite model of asthma, protect from lung function decline during an IL-13 challenge model in mice, and decrease IL-13-induced MUC5AC gene expression in primary airway epithelial cells from asthmatic participants. These results suggest that position 223 within the CRD of SP-A2 may modulate several outcomes relevant to asthma, and that short peptides of SP-A2 retain anti-inflammatory properties similar to that of the endogenous protein.